Campath-1G
Alternative Names: Campath IgG; Campath-1-IgG antibodyLatest Information Update: 02 Jul 2023
At a glance
- Originator University of Cambridge
- Developer GSK
- Class Monoclonal antibodies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Graft-versus-host disease; Transplant rejection
Most Recent Events
- 22 Jan 2001 Glaxo Wellcome has merged with SmithKline Beecham to form GlaxoSmithKline
- 27 Jan 1999 A study comparing T-cell depletion with immunosuppression has been added to the adverse events and therapeutic trials section
- 08 Jun 1998 A study in children has been added to the therapeutic trials section